Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Polycystic ovarian syndrome (PCOS) affects 18–22% of women at reproductive age. We conducted a systematic review and meta-analysis evaluating the expected benefits of lifestyle (exercise plus diet) interventions on the reproductive endocrine profile in women with PCOS. Potential studies were identified by systematically searching PubMed, CINAHL and the Cochrane Controlled Trials Registry (1966–April 30, 2013) systematically using key concepts of PCOS. Significant improvements were seen in women receiving lifestyle intervention vs usual care in follicle-stimulating hormone (FSH) levels, mean difference (MD) 0.39 IU/l (95% CI 0.09 to 0.70, P =0.01), sex hormone-binding globulin (SHBG) levels, MD 2.37 nmol/l (95% CI 1.27 to 3.47, P <0.0001), total testosterone levels, MD −0.13 nmol/l (95% CI −0.22 to −0.03, P =0.008), androstenedione levels, MD −0.09 ng/dl (95% CI −0.15 to −0.03, P =0.005), free androgen index (FAI) levels, MD −1.64 (95% CI −2.94 to −0.35, P =0.01) and Ferriman–Gallwey (FG) score, MD −1.01 (95% CI −1.54 to −0.48, P =0.0002). Significant improvements were also observed in women who received exercise-alone intervention vs usual care in FSH levels, MD 0.42 IU/l (95% CI 0.11 to 0.73, P =0.009), SHBG levels, MD 3.42 nmol/l (95% CI 0.11 to 6.73, P =0.04), total testosterone levels, MD −0.16 nmol/l (95% CI −0.29 to −0.04, P =0.01), androstenedione levels, MD −0.09 ng/dl (95% CI −0.16 to −0.03, P =0.004) and FG score, MD −1.13 (95% CI −1.88 to −0.38, P =0.003). Our analyses suggest that lifestyle (diet and exercise) intervention improves levels of FSH, SHBG, total testosterone, androstenedione and FAI, and FG score in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Weight loss and lifestyle changes have proven to be effective in restoring menstrual regularity and reproductive function, improving hyperandrogenism, glucose and lipid metabolism, and insulin sensitivity, thus reducing cardiovascular risk in women with PCOS [18–20].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials
Maher, C. G., Sherrington, C., Herbert, R. D., Moseley, A. M., & Elkins, M. (2003) · Physical Therapy · doi:10.1093/ptj/83.8.713 · Cited by 4,808
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121 · cited 1×
“PCOS was first reported in the 1935 by Stein and 92 Leventhal[2] and is characterised by clinical or biochemical hyperandrogenism (clinical 93 manifestations are hirsutism, android alopecia and acne), oligo/amenorrhea (infrequent or no 94”
BackgroundMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020815 · Cited by 530
Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.018 · Cited by 444
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292
Hoeger, K. M., Kochman, L., Wixom, N., Craig, K., Miller, R. K., & Guzick, D. S. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.104 · Cited by 278
Thomson, R. L., Buckley, J. D., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0751 · Cited by 277
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Hoeger, K., Davidson, K., Kochman, L., Cherry, T., Kopin, L., & Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0461 · Cited by 256
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
Guzick, D. S., Wing, R., Smith, D., Berga, S. L., & Winters, S. J. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56632-1 · Cited by 246
Jedel, E., Labrie, F., Odén, A., Holm, G., Nilsson, L., Janson, P. O., Lind, A.-K., Ohlsson, C., & Stener-Victorin, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2010 · Cited by 223
Vigorito, C., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Lucci, R., De Lorenzo, A., Tafuri, D., Lombardi, G., Colao, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2794 · Cited by 211
Thomson, R. L., Buckley, J. D., Lim, S. S., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.001 · Cited by 207
Stener-Victorin, E., Jedel, E., Janson, P. O., & Sverrisdottir, Y. B. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2009 · Cited by 194
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.002 · Cited by 138
Nybacka, Å., Carlström, K., Ståhle, A., Nyrén, S., Hellström, P. M., & Hirschberg, A. L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.006 · Cited by 138
Effects of Exercise and Nutritional Counseling in Women with Polycystic Ovary Syndrome
Bruner, B., Chad, K., & Chizen, D. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-007 · Cited by 133
Karimzadeh, M. A., & Javedani, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.078 · Cited by 118
Cobin, R. H., Futterweit, W., Nestler, J. E., Reaven, G. M., Jellinger, P. S., Handelsman, Y., Redmond, G. P., & Thatcher, S. S. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.125 · Cited by 117
Palomba, S., Falbo, A., Giallauria, F., Russo, T., Rocca, M., Tolino, A., Zullo, F., & Orio, F. (2010) · Human Reproduction · doi:10.1093/humrep/deq254 · Cited by 111
Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007) · Appetite · doi:10.1016/j.appet.2007.03.222 · Cited by 103
Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome
BROWN, A. J., SETJI, T. L., SANDERS, L. L., LOWRY, K. P., OTVOS, J. D., KRAUS, W. E., & SVETKEY, P. L. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31818c6c0c · Cited by 101
Ovarian control of follicle development
Erickson, G. F., & Danforth, D. R. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90147-7 · Cited by 90 · cited 2×
“The resultant oestrogen environment alters the 104 hypothalamic release of GnRH and leads to an increase in LH secretion and suppression of 105 FSH secretion by the pituitary[8, 10].”
BackgroundFux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85
Metformin versus lifestyle changes in treating women with polycystic ovary syndrome
Curi, D. D. G., Fonseca, A. M., Marcondes, J. A. M., Almeida, J. A. M., Bagnoli, V. R., Soares, J. M., & Baracat, E. C. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.583957 · Cited by 60
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Lee, P. A., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.048 · Cited by 56
Thomson, R. L., Brinkworth, G. D., Noakes, M., Clifton, P. M., Norman, R. J., & Buckley, J. D. (2012) · Human Reproduction · doi:10.1093/humrep/des138 · Cited by 55
Stener‐Victorin, E., Baghaei, F., Holm, G., Janson, P. O., Olivecrona, G., Lönn, M., & Mannerås-Holm, L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.010 · Cited by 52
Endocrine and paracrine control of oocyte development
Danforth, D. R. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90148-5 · Cited by 51 · cited 1×
“The resultant oestrogen environment alters the 104 hypothalamic release of GnRH and leads to an increase in LH secretion and suppression of 105 FSH secretion by the pituitary[8, 10].”
BackgroundOrio, F., Giallauria, F., Palomba, S., Manguso, F., Orio, M., Tafuri, D., Lombardi, G., Carmina, E., Colao, A., & Vigorito, C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03117.x · Cited by 50
Martinez-Garcia, M. A., Gambineri, A., Alpanes, M., Sanchon, R., Pasquali, R., & Escobar-Morreale, H. F. (2012) · Human Reproduction · doi:10.1093/humrep/des335 · Cited by 50
Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
Rachoń, D. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1299765 · Cited by 50
Exercise Therapy in Polycystic Ovary Syndrome
Hoeger, K. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992929 · Cited by 43
[Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].
Ma, L., Jin, L., Yu, Q., & Xu, L. (2007) · PubMed · Cited by 8
Cited by
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Cena, H., Chiovato, L., & Nappi, R. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa285 · Cited by 356
“Endocrine and metabolic effects of GLP-1 RAs Reduction in body weight has been demonstrated to improve hyperandrogenism, reproductive function, and metabolic parameters such as hyperlipidemia, and glycemic control, as well as hypertension, in women with PCOS (71-73).”
BackgroundLifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
Ostman, C., Smart, N. A., Morcos, D., Duller, A., Ridley, W., & Jewiss, D. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0590-y · Cited by 234
“Analyses of lifestyle interventions are yet to show a reduction in the proportion of participants who meet the diagnostic criteria for MetS [3], although summary data are available outlining significant improvements in both body composition and metabolic profile measures with lifestyle intervention in women with metab…”
BackgroundSelf-citationJeanes, Y. M., & Reeves, S. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000287 · Cited by 194
Metadata
- Authors
- Haqq, L., McFarlane, J., Dieberg, G., & Smart, N.
- Affiliations
- University of New England (AU)
- Corresponding author
- Smart, Neil
- Venue
- Endocrine Connections
- Publisher
- Bioscientifica
- Published
- 2014-03
- Volume
- 3
- Issue
- 1
- Pages
- 36-46
- ISSN
- 2049-3614 (ISSN-L)
- PMC
- PMC3938041
- OpenAlex
- W2106824723
- Cited by
- 101
- References
- 42
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 14 · 2021: 9 · 2020: 11 · 2019: 11 · 2018: 4 · 2017: 15 · 2016: 4 · 2015: 4 · 2014: 4
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Endocrine Connections (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EPubDev Repository (submittedVersion)
- RUNE (Research UNE) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, lifestyle intervention, physical activity, dietary intervention, follicle-stimulating hormone, sex hormone-binding globulin, total testosterone, androstenedione, free androgen index, Ferriman-Gallwey score, hirsutism, insulin resistance, hyperandrogenism, ovulation induction, anovulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.